Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease

Am J Respir Crit Care Med. 2012 Jul 1;186(1):5-7. doi: 10.1164/rccm.201205-0883ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Male
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin